Perspectives and possibilities of preserving reproductive function in patients receiving antitumor treatment. Clinical observation

Cover Page

Cite item

Full Text

Abstract

Currently, treatment of patients with early primary operable BRCA mutation-associated breast cancer requires integrative approach. A mutation in BRCA1/2 genes is a prognostically unfavorable factor increasing the risk of cancer of the contralateral breast, as well as ovaries, pancreas, fallopian tubes, and primary peritoneal cancer. In this clinical observation, an integrative multidisciplinary approach to treatment of a young patient with luminal B breast cancer is described which allowed to preserve the patient’s fertility and achieve pregnancy using assisted reproductive technologies.

High effectiveness of the chosen treatment tactics in the framework of integrative approach in a specialized medical facility with experience in treatment of oncological diseases and preservation of reproductive function confirmed by clinical data and results of laboratory and instrumental exams is demonstrated.

About the authors

N. M. Kutakov

Clinical Hospital “Lapino” of the “Mother and Child” Group of companies

111 1st Uspenskoe Shosse, Lapino, Moscow region 143081

Russian Federation

D. A. Chekini

Clinical Hospital “Lapino” of the “Mother and Child” Group of companies

Author for correspondence.
Email: d.chekini@mcclinics.ru

Jennet Ashirovna Chekini

111 1st Uspenskoe Shosse, Lapino, Moscow region 143081

Russian Federation

References

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2023 ABV-Press

License URL: https://mdonco.abvpress.ru/jour/about/editorialPolicies

СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77-81466 от  03.08.2021.